You searched for multiple sclerosis - Page 3 of 20

Your search for multiple sclerosis returned 200 results

Sort Results:

Relevant Recent

Neurology Information Center

Multiple Sclerosis Guidelines: AAN’s Recommendations for Initiating, Switching, Stopping Disease-Modifying Therapy

April 26, 2018

The new guidelines focus on helping clinicians decide when to initiate, switch, or discontinue disease-modifying therapies for multiple sclerosis.

Neurology Information Center

FDA approves Ocrevus to treat primary progressive multiple sclerosis

April 1, 2017

The FDA approved Ocrevus to treat adults with primary progressive multiple sclerosis and relapsing forms of the disease.

Neurology Information Center

Stem cell therapy may be effective for multiple sclerosis

February 27, 2017

Younger age, relapsing forms of MS, fewer prior immunotherapy treatments, and lower baseline EDSS score were factors associated with better outcomes for stem cell transplantation.

Neurology Information Center

Early interferon beta-1b treatment beneficial in patients with multiple sclerosis

August 16, 2016

Results of the BENEFIT 11 trial show that many clinical outcomes were improved with earlier interferon beta-1b treatment.

Web Exclusives

Coffee may lower multiple sclerosis risk

March 1, 2015

Patients who regularly drank at least four cups of coffee a day were one-third less likely to have MS, compared with people who avoided coffee.

Web Exclusives

HPV vaccine not associated with increased multiple sclerosis risk

January 7, 2015

In primary and secondary analyses, vaccination was not associated with an increased risk of multiple sclerosis or other demyelinating diseases.

Web Exclusives

Dietary salt linked to an increase in multiple sclerosis activity

September 4, 2014

Patients with multiple sclerosis who had high levels of sodium intake were 3.4 times more likely to develop a new lesion.

Evidence-Based Medicine

Dalfampridine approved for multiple sclerosis

May 11, 2010

Level 3: Lacking direct evidence Dalfampridine (Ampyra) extended release tablets, previously called Fampridine-SR, have been approved by the FDA to improve walking in patients with multiple sclerosis. In two clinical trials with 507 patients, the drug was associated with consistent improvement in walking speed on a 25-foot walk when compared with placebo (NNT 4). However,…

Cardiovascular Disease Information Center

Early-Stage Hypertension Linked to Increased Prevalence of Retinal Atherosclerosis

July 26, 2021

The association between high blood pressure and the prevalence of retinal atherosclerosis was examined.

Features

Amyotrophic Lateral Sclerosis: Update for the Primary Care Clinician

May 11, 2018

Patients with ALS require multidisciplinary care and rehabilitative interventions; maximizing independent function and quality of life are the goals.

Next post in Features

Active Filters

Your search for multiple sclerosis returned 200 results

Sort Results:

Multiple Sclerosis Guidelines: AAN’s Recommendations for Initiating, Switching, Stopping Disease-Modifying Therapy

FDA approves Ocrevus to treat primary progressive multiple sclerosis

Stem cell therapy may be effective for multiple sclerosis

Early interferon beta-1b treatment beneficial in patients with multiple sclerosis

Coffee may lower multiple sclerosis risk

HPV vaccine not associated with increased multiple sclerosis risk

Dietary salt linked to an increase in multiple sclerosis activity

Dalfampridine approved for multiple sclerosis

Early-Stage Hypertension Linked to Increased Prevalence of Retinal Atherosclerosis

Amyotrophic Lateral Sclerosis: Update for the Primary Care Clinician

Case Study: Cardiovascular Complications of Chronic Obstructive Pulmonary Disease